{"id":"NCT00552032","sponsor":"Organon and Co","briefTitle":"Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)","officialTitle":"A Double-blind Placebo-controlled, Randomized, Parallel-group, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy SNORE Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08-01","primaryCompletion":"2010-01-01","completion":"2010-01-01","firstPosted":"2007-11-01","resultsPosted":"2012-01-31","lastUpdate":"2024-05-20"},"enrollment":132,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Adenoids Hypertrophy"],"interventions":[{"type":"DRUG","name":"Mometasone Furoate nasal spray","otherNames":["SCH 032088"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Mometasone Furoate nasal spray","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether 8 weeks treatment with mometasone furoate nasal spray (MFNS), twice daily, is safe and effective in treating adenoid hypertrophy in children.","primaryOutcome":{"measure":"Change From Baseline in Adenoid/Choana (A/C) Index Grade","timeFrame":"Baseline (visit 2), Weeks 4 (visit 3), Week 8 (visit 4)","effectByArm":[{"arm":"Mometasone Furoate Nasal Spray (MFNS)","deltaMin":0.3,"sd":0.6},{"arm":"Placebo Nasal Spray","deltaMin":0.2,"sd":0.5}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":66},"commonTop":["Pyrexia","Nasopharyngitis","Pharyngitis","Epistaxis","Pharyngotonsillitis"]}}